Skip to main content
SpringerLink
Log in

CT, MRI, SPECT, and PET in DLB

  • Chapter
  • First Online:
Dementia with Lewy Bodies

Abstract

Neuroimaging has been used to diagnose dementia with Lewy bodies (DLB) for the past two decades. Undoubtedly, structural and functional neuroimaging should be considered strong diagnostic tools; however, there is still limited evidence regarding early diagnosis. In this chapter, we summarize the accepted findings on neuroimaging modalities (computed topography [CT], magnetic resonance imaging [MRI], single-photon emission computed tomography [SPECT], and positron emission tomography [PET]) in probable DLB. We also review the findings seen during the early stages of DLB. Lastly, we briefly discuss the usefulness of these imaging modalities for the early diagnosis of DLB.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Burton EJ, Barber R, Mukaetova-Ladinska EB, et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain. 2009;132:195–203.

    Article  CAS  PubMed  Google Scholar 

  2. O’Brien J, Paling S, Barber R, et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD and vascular dementia. Neurology. 2001;56:1386–8.

    Article  PubMed  Google Scholar 

  3. Boeve BF. Mild cognitive impairment associated with underlying Alzheimer’s disease versus Lewy body disease. Parkinsonism Relat Disord. 2012;18:S41–4.

    Article  PubMed  Google Scholar 

  4. Ferman TJ, Smith GE, Kantarci K, et al. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013;81:2032–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Fujishiro H, Nakamura S, Kitazawa M, et al. Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy. J Neurol Sci. 2012;315:115–19.

    Article  PubMed  Google Scholar 

  6. Donaghy PC, O’Brien JT, Thomas AJ. Prodromal dementia with Lewy bodies. Psychol Med. 2015;45:259–68.

    Article  CAS  PubMed  Google Scholar 

  7. Fujishiro H, Nakamura S, Sato K, et al. Prodromal dementia with Lewy bodies. Geriatr Gerontol Int. 2015;15:817–26.

    Article  PubMed  Google Scholar 

  8. Gungor I, Sarro L, Graf-Radford J, et al. Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer’s disease. Parkinsonism Relat Disord. 2015;21:1–4.

    Article  Google Scholar 

  9. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;27:1863–72.

    Article  Google Scholar 

  10. McKeith I, O’Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13.

    Article  PubMed  Google Scholar 

  11. Mak E, Su L, Williams GB, et al. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther. 2014;6:18–27.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Albin RL, Minoshima S, D’Amato CJ, et al. Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 1996;47:462–8.

    Article  CAS  PubMed  Google Scholar 

  13. Minoshima S, Foster NL, Sima AA, et al. Alzheimer’s disease versus dementia with Lewy bodies; cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50:358–65.

    Article  CAS  PubMed  Google Scholar 

  14. Iseki E, Marui W, Kosaka K, et al. Degenerative terminals of the perforant pathway are human !-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett. 1998;258:81–4.

    Article  CAS  PubMed  Google Scholar 

  15. Katsuse O, Iseki E, Marui W, et al. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurosci. 2003;211:29–35.

    CAS  Google Scholar 

  16. Yamamoto R, Iseki E, Murayama N, et al. Investigation of Lewy pathology in the visual pathway. J Neurosci. 2006;246:95–101.

    Google Scholar 

  17. Kasanuki K, Iseki E, Fujishiro H, et al. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies. J Neurol Sci. 2012;314:111–19.

    Article  CAS  PubMed  Google Scholar 

  18. Parent A. Carpenter’s human neuroanatomy. 9th ed. Baltimore: Williams & Wilkins; 1996. p. 773–80.

    Google Scholar 

  19. Mukaetova-Ladinska EB, Andras A, Milne J, et al. Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. J Neuropathol Exp Neurol. 2013;72:53–60.

    Article  CAS  PubMed  Google Scholar 

  20. Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer’s disease. Neurology. 1998;51:125–30.

    Article  CAS  PubMed  Google Scholar 

  21. Aarsland D, Perry R, Brown A, et al. Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol. 2005;58:773–6.

    Article  PubMed  Google Scholar 

  22. Fujishiro H, Ferman TJ, Boeve BF, et al. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol. 2008;67:649–56.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Haxby JV, Grady CL, Koss E, et al. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in dementia of the Alzheimer type. Arch Neurol. 1990;47:977–80.

    Article  PubMed  Google Scholar 

  24. Mega MS, Chen SS, Thompson PM, et al. Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer’s disease. Neuroimage. 1997;5:147–53.

    Article  CAS  PubMed  Google Scholar 

  25. Mosconi L, Pupi A, De Cristofaro MT, et al. Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer’s disease. J Nucl Med. 2004;45:382–92.

    PubMed  Google Scholar 

  26. Graff-Radford J, Murray ME, Lowe VJ, et al. Dementia with Lewy bodies: basis of cingulate island sign. Neurology. 2014;26(83):801–9.

    Article  Google Scholar 

  27. Lim SM, Katsifis A, Villemagne VL, et al. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med. 2009;50:1638–45.

    Article  CAS  PubMed  Google Scholar 

  28. Imamura T, Ishii K, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer’s disease: a comparative study using positron emission tomography. Neurosci Lett. 1997;235:49–52.

    Article  CAS  PubMed  Google Scholar 

  29. Chiba Y, Fujishiro H, Ota K, et al. Clinical profiles of dementia with Lewy bodies with and without Alzheimer’s disease-like hypometabolism. Int J Geriatr Psychiatry. 2015;30:316–23.

    Article  PubMed  Google Scholar 

  30. Fujishiro H, Iseki E, Kasanuki K, et al. Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions. Int J Geriatr Psychiatry. 2012;27:1138–46.

    Article  PubMed  Google Scholar 

  31. Fujishiro H, Iseki E, Kasanuki K, et al. A follow up study of non-demented patients with primary visual cortical hypometabolism: prodromal dementia with Lewy bodies. J Neurol Sci. 2013;15(334):48–54.

    Article  Google Scholar 

  32. Daizo Kondo, Kazumi Ota, Koji Kasanuki, et al. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: a follow-up study in a memory clinic. doi:http://dx.doi.org/10.1016/j.jns.2016.08.011.

  33. Klunk WE, H E, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol. 2004;55(3):306–19.

    Article  CAS  PubMed  Google Scholar 

  34. Shimada H, Shinotoh H, Hirano S, et al. β-amyloid in lewy body disease is related to Alzheimer’s disease-like atrophy. Mov Disord. 2013;28:169–75.

    Article  CAS  PubMed  Google Scholar 

  35. Ossenkoppele R, Jansen WJ, Rabinovici GD, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;19(313):1939–49.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA

    Koji Kasanuki

  2. Juntendo Tokyo Koto Geriatric Medical Center PET/CT Dementia Research Center, 3-3-20 Shinsuna, Koto-ku, Tokyo, 136-0075, Japan

    Koji Kasanuki & Eizo Iseki

  3. Department of Psychiatry, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan

    Koji Kasanuki & Eizo Iseki

Authors
  1. Koji Kasanuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eizo Iseki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koji Kasanuki .

Editor information

Editors and Affiliations

  1. Yokohama City University, Yokohama, Kanagawa, Japan

    Kenji Kosaka

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan KK

About this chapter

Cite this chapter

Kasanuki, K., Iseki, E. (2017). CT, MRI, SPECT, and PET in DLB. In: Kosaka, K. (eds) Dementia with Lewy Bodies. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55948-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55948-1_10

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55946-7

  • Online ISBN: 978-4-431-55948-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation